[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Microbiology](https://durgical.com/en/microbiology/) › [General microbiology](https://durgical.com/en/microbiology/general/) › Antimicrobial susceptibility testing

# Antimicrobial susceptibility testing

- Laboratory diagnosis

Susceptibility testing shows which antimicrobials stop the organism that grew, so treatment can be targeted.

Updated Nov 16, 2026

## Key points

- MIC = lowest concentration that inhibits visible growth; compare it only with that drug's breakpoint.
- Larger inhibition zone in disk diffusion = lower MIC = more susceptible.
- [Cefoxitin](https://durgical.com/en/pharmacology/cefoxitin/) disk detects mecA-mediated resistance ([MRSA](https://durgical.com/en/conditions/mrsa-and-other-multidrug-resistant-organism-infections/)); the D-test detects inducible [clindamycin](https://durgical.com/en/pharmacology/clindamycin/) resistance.
- Breakpoints depend on organism, drug and site; meningitis breakpoints are stricter.
- The local antibiogram guides empirical therapy; individual results guide de-escalation.

On this page

- The basics Key points
- What it is
- How to think about it
- Key facts
- Step by step
- Ways to test susceptibility
- Common traps
- Memory aid

- Clinical Clinical notes

- Study Test yourself

- Connections Connections

## What it is

Antimicrobial susceptibility testing (AST) exposes a pure isolate to antimicrobials and measures whether its growth is inhibited. The result, a minimum inhibitory concentration (MIC) or a zone of inhibition, is compared with clinical breakpoints and reported as susceptible, intermediate or resistant. Pooled results for a hospital form the antibiogram, which guides empirical treatment before results are available.

## How to think about it

Susceptibility testing asks one question: at drug levels a patient can actually reach at the site of infection, will growth stop? The MIC measures what the organism needs; the breakpoint encodes what the body can deliver. Susceptible, intermediate or resistant is simply the comparison of the two, which is why a raw MIC means nothing without that drug's breakpoint for that site.

## Key facts

- Susceptible means a good chance of success at standard exposure; resistant means likely failure; intermediate (EUCAST now 'susceptible, increased exposure') may work with higher exposure or where the drug concentrates.
- MIC numbers cannot be compared across drugs: each drug has its own breakpoints.
- Breakpoints are set by expert committees from MIC distributions, pharmacokinetics and clinical outcomes, and they change over time.
- Breakpoints can differ by site: penicillin and [ceftriaxone](https://durgical.com/en/pharmacology/ceftriaxone/) breakpoints for [pneumococcus](https://durgical.com/en/microbiology/streptococcus-pneumoniae/) are lower for meningitis than for pneumonia.
- Intrinsic resistance is predictable and often not reported, such as enterococci to cephalosporins or *Pseudomonas* to many older drugs.
- The antibiogram summarizes the percentage of first isolates per patient that are susceptible to each drug, usually each year.

## Step by step

- Start from a pure isolate that is clinically relevant (not a likely contaminant or colonizer).
- Prepare a standardized inoculum, matched to a turbidity standard, so every test starts with the same number of bacteria.
- Run the test: broth dilution, disk diffusion, a gradient diffusion strip or an automated system.
- Incubate under standard conditions, usually overnight for common bacteria.
- Read the MIC (lowest concentration with no visible growth) or measure the zone diameter around each disk.
- Interpret against current breakpoints (for example CLSI or EUCAST), which depend on the organism, drug and infection site.
- Report selectively: show the narrow-spectrum options first and release broader drugs when needed.

## Ways to test susceptibility

| Method | Result | Notes |
| --- | --- | --- |
| Broth microdilution | MIC | Reference method; doubling dilutions of each drug in small wells |
| Disk diffusion | Zone diameter | Cheap and flexible; a larger zone corresponds to a lower MIC |
| Gradient diffusion strip | MIC read where the growth ellipse meets the strip | Useful for single drugs and fastidious organisms |
| Automated systems | MIC from miniaturized broth panels | Faster, often combined with identification |
| [Phenotypic resistance tests](https://durgical.com/en/conditions/mrsa-and-other-multidrug-resistant-organism-infections/) | Presence of a mechanism | Cefoxitin screen for MRSA; D-test for inducible clindamycin resistance; carbapenemase tests such as the modified carbapenem inactivation method |
| [Genotypic tests](https://durgical.com/en/conditions/mrsa-and-other-multidrug-resistant-organism-infections/) | Resistance genes | mecA, vanA, KPC, NDM and OXA-48-like genes; fast but do not cover every mechanism |

## Clinical notes

- Carbapenemase-producing *[Klebsiella pneumoniae](https://durgical.com/en/microbiology/klebsiella-pneumoniae/)* (KPC) is endemic in Colombian hospitals, so carbapenem-resistant isolates are tested for carbapenemases.
- An [oxacillin](https://durgical.com/en/pharmacology/oxacillin/) - or cefoxitin-resistant *S. aureus* is MRSA: resistant to nearly all [beta-lactams](https://durgical.com/en/pharmacology/classes/beta-lactams/) except anti-MRSA cephalosporins.
- *[Mycobacterium tuberculosis](https://durgical.com/en/microbiology/mycobacterium-tuberculosis/)* needs specialized phenotypic or molecular testing at reference laboratories.

## Common traps

- **A lower MIC always means the better drug**: MICs cannot be compared across drugs, because each drug has its own breakpoint.
- **A small inhibition zone is a good sign**: in disk diffusion a smaller zone means a higher MIC and less susceptibility.
- **A staphylococcus that tests clindamycin-susceptible is always safe to treat with it**: if it is [erythromycin](https://durgical.com/en/pharmacology/erythromycin/) -resistant, the D-test can reveal inducible resistance that appears during treatment.
- **The same breakpoint applies to pneumonia and meningitis**: breakpoints depend on the site, and pneumococcal meningitis breakpoints are stricter because less drug reaches the CSF.
- **Every organism that grows should be tested**: testing is for clinically relevant isolates, since results on contaminants or colonizers mislead treatment.

## Memory aid

Low MIC, large ring: the less drug it takes and the wider the clear zone, the better the drug works.

## Test yourself

Think of the answer, then tap the question to see it.

## An *S. aureus* isolate is resistant to cefoxitin. What does that mean for the choice of beta-lactam?

It is MRSA (mecA-mediated): resistant to nearly all beta-lactams except anti-MRSA cephalosporins, whatever the other beta-lactam results look like.

## The same pneumococcal ceftriaxone MIC is reported susceptible from sputum but resistant from CSF. Why?

Breakpoints depend on the site: they are lower for meningitis because less drug reaches the CSF than the lung.

## A staphylococcus is erythromycin-resistant and clindamycin-susceptible. Which test is needed before relying on clindamycin?

The D-test. If erythromycin induces resistance, the clindamycin zone flattens into a D shape, and clindamycin may fail during treatment.

## A carbapenem-resistant *Klebsiella pneumoniae* grows in a Colombian ICU. Which further test is done, and why?

A carbapenemase test (phenotypic or for genes such as KPC): carbapenemase-producing *Klebsiella* is endemic in Colombian hospitals, and the mechanism shapes treatment and infection control.

## Before culture results arrive, how is the empirical antibiotic chosen, and what changes when the susceptibility report comes back?

From the local antibiogram, which shows the percentage of isolates susceptible to each drug; the individual result then guides de-escalation to a narrower drug.

[Add to my cards (5)](https://durgical.app/estudiar/?add=/en/microbiology/general/antimicrobial-susceptibility-testing/)

## Connections

## Related 5

- [Gene transfer in bacteria](https://durgical.com/en/microbiology/general/gene-transfer-in-bacteria/)
- [Bacterial genome and mutation](https://durgical.com/en/microbiology/general/bacterial-genome-and-mutation/)
- [Molecular diagnosis of infection](https://durgical.com/en/microbiology/general/molecular-diagnosis-of-infection/)
- [Identifying bacteria in the lab](https://durgical.com/en/microbiology/general/identifying-bacteria-in-the-lab/)
- [Culture media and culture](https://durgical.com/en/microbiology/general/culture-media-and-culture/)

## Microorganisms 8

- [*Staphylococcus aureus*](https://durgical.com/en/microbiology/staphylococcus-aureus/)
- [*Enterococcus*](https://durgical.com/en/microbiology/enterococcus/)
- [*Klebsiella pneumoniae*](https://durgical.com/en/microbiology/klebsiella-pneumoniae/)
- [*Pseudomonas aeruginosa*](https://durgical.com/en/microbiology/pseudomonas-aeruginosa/)
- [*Acinetobacter baumannii*](https://durgical.com/en/microbiology/acinetobacter-baumannii/)
- [*Streptococcus pneumoniae*](https://durgical.com/en/microbiology/streptococcus-pneumoniae/)
- [*Escherichia coli*](https://durgical.com/en/microbiology/escherichia-coli/)
- [*Mycobacterium tuberculosis*](https://durgical.com/en/microbiology/mycobacterium-tuberculosis/)

## Related conditions 4

- [MRSA and other multidrug-resistant organism infections](https://durgical.com/en/conditions/mrsa-and-other-multidrug-resistant-organism-infections/)
- [Sepsis and septic shock](https://durgical.com/en/conditions/sepsis-and-septic-shock/)
- [Bacterial meningitis](https://durgical.com/en/conditions/bacterial-meningitis/)
- [Healthcare-associated infections (CLABSI, CAUTI, VAP)](https://durgical.com/en/conditions/healthcare-associated-infections/)

## In Pharmacology 8

- [Vancomycin](https://durgical.com/en/pharmacology/vancomycin/)
- [Oxacillin](https://durgical.com/en/pharmacology/oxacillin/)
- [Carbapenems](https://durgical.com/en/pharmacology/classes/carbapenems/)
- [Meropenem](https://durgical.com/en/pharmacology/meropenem/)
- [Clindamycin](https://durgical.com/en/pharmacology/clindamycin/)
- [Ceftriaxone](https://durgical.com/en/pharmacology/ceftriaxone/)
- [Benzylpenicillin (penicillin G)](https://durgical.com/en/pharmacology/benzylpenicillin/)
- [Colistin (colistimethate)](https://durgical.com/en/pharmacology/colistin/)

[← General microbiology](https://durgical.com/en/microbiology/general/)

Educational content on microorganisms; not a treatment guide and no substitute for a health professional's advice. No doses are given.

Sources: [Antibiotic Sensitivity Test: MedlinePlus Medical Test](https://medlineplus.gov/lab-tests/antibiotic-sensitivity-test/) (MedlinePlus (NLM), 2025); [Sensitivity analysis: MedlinePlus Medical Encyclopedia](https://medlineplus.gov/ency/article/003741.htm) (MedlinePlus (NLM), 2025); [Core Elements of Hospital Antibiotic Stewardship Programs](https://www.cdc.gov/antibiotic-use/core-elements/hospital.html) (CDC, 2024).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/microbiology/general/antimicrobial-susceptibility-testing/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/microbiology/general/antimicrobial-susceptibility-testing/
